Trial intelligence / Profile preview

Minocycline in the treatment of depression in patients with HIV infection

IRCT201405271556N57Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of minocycline in major depressive disorder (MDD), sponsored by Tehran University of Medical Sciences. Started Jun 2014; status: completed.

02

Drugs

minocycline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on IRCT201405271556N57.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201405271556N57.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call